Research use only. Read more

Cognitive

Selank

A synthetic analog of tuftsin researched for anxiolytic effects without sedation or withdrawal in animal and human models.

Quick facts

Molecular weight

752 Da

Half-life

0.5 h

Frequency

daily

Admins / wk

7

Routes

Intranasal / SubQ

Typical dose

250 mcg–750 mcg

Mechanism & positioning

A synthetic analog of tuftsin researched for anxiolytic effects without sedation or withdrawal in animal and human models.

Researched for: GABAergic modulation, anxiolytic effects, enkephalin stabilisation.

Reconstitution defaults

Default vial

10 mg

BAC water

2 mL

Concentration

5000 mcg/mL

Doses per vial

~40

Other stocked vial sizes: 30 mg.

Calculate with this peptide

Documented pairwise interactions

  • caution

    Selank + Semax

    Often investigated together; consider stagger to attribute observed effects.

References

  • Zozulia AA et al., Zh Nevrol Psikhiatr, 2008.

Related peptides in the Cognitive class

Frequently asked questions about Selank

What is the typical research dose range for Selank?
Selank is most commonly investigated at 250 mcg–750 mcg per administration, daily. These values reflect documented research-stage protocols and are not medical recommendations.
What is the half-life of Selank?
Selank has an approximate plasma half-life of 0.5 hours. Practical steady state is reached after roughly five half-lives — about 0 days under continuous administration.
How is Selank administered in research protocols?
Published research uses intranasal or subq administration. Typical reconstitution is 10 mg vial in 2 mL of bacteriostatic water, producing a concentration of 5000 mcg/mL.
What vial sizes are commonly available for Selank?
Common stocked vial sizes are 10 mg, 30 mg. The 10 mg vial is the most-used default in published protocols.